These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 17855632

  • 1. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.
    Morton LM, Landgren O, Chatterjee N, Castenson D, Parsons R, Hoover RN, Engels EA.
    Blood; 2007 Dec 15; 110(13):4599-605. PubMed ID: 17855632
    [Abstract] [Full Text] [Related]

  • 2. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A, Baecklund E, Backlin C, Ekman T, Molin D, Tufveson G, Fernberg P, Sundström C, Pauksens K, Enblad G.
    Acta Oncol; 2014 May 15; 53(5):669-79. PubMed ID: 24164103
    [Abstract] [Full Text] [Related]

  • 3. Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.
    Kinch A, Sundström C, Tufveson G, Glimelius I.
    Leuk Lymphoma; 2016 Oct 15; 57(10):2351-8. PubMed ID: 27104753
    [Abstract] [Full Text] [Related]

  • 4. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK.
    Transplantation; 2018 Sep 15; 102(9):1553-1562. PubMed ID: 29485513
    [Abstract] [Full Text] [Related]

  • 5. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients.
    Boyle GJ, Michaels MG, Webber SA, Knisely AS, Kurland G, Cipriani LA, Griffith BP, Fricker FJ.
    J Pediatr; 1997 Aug 15; 131(2):309-13. PubMed ID: 9290623
    [Abstract] [Full Text] [Related]

  • 6. Transplantation for congenital heart disease is associated with an increased risk of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in children.
    Offor UT, Bacon CM, Roberts J, Powell J, Brodlie M, Wood K, Windebank KP, Flett J, Hewitt T, Rand V, Hasan A, Parry G, Gennery AR, Reinhardt Z, Bomken S.
    J Heart Lung Transplant; 2021 Jan 15; 40(1):24-32. PubMed ID: 33339556
    [Abstract] [Full Text] [Related]

  • 7. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
    Sokal EM, Antunes H, Beguin C, Bodeus M, Wallemacq P, de Ville de Goyet J, Reding R, Janssen M, Buts JP, Otte JB.
    Transplantation; 1997 Nov 27; 64(10):1438-42. PubMed ID: 9392308
    [Abstract] [Full Text] [Related]

  • 8. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME, Pelletier RP, Porcu P, Martin SI, Quinion CD, Geyer SM, Caligiuri MA, Baiocchi RA.
    Transplantation; 2015 Jun 27; 99(6):1220-5. PubMed ID: 25427163
    [Abstract] [Full Text] [Related]

  • 9. Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients.
    L'Huillier AG, Dipchand AI, Ng VL, Hebert D, Avitzur Y, Solomon M, Ngan BY, Yeung S, Stephens D, Punnett AS, Barton M, Allen UD.
    Transplantation; 2019 Nov 27; 103(11):e369-e374. PubMed ID: 31385930
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients.
    Courtwright AM, Burkett P, Divo M, Keller S, Rosas IO, Trindade A, Mody GN, Singh SK, El-Chemaly S, Camp PC, Goldberg HJ, Mallidi HR.
    Ann Thorac Surg; 2018 Feb 27; 105(2):441-447. PubMed ID: 29223419
    [Abstract] [Full Text] [Related]

  • 16. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.
    Hézode C, Duvoux C, Germanidis G, Roudot-Thoraval F, Vincens AL, Gaulard P, Cherqui D, Pawlotsky JM, Dhumeaux D.
    Hepatology; 1999 Sep 27; 30(3):775-8. PubMed ID: 10462385
    [Abstract] [Full Text] [Related]

  • 17. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.
    Limaye AP, Huang ML, Atienza EE, Ferrenberg JM, Corey L.
    J Clin Microbiol; 1999 Apr 27; 37(4):1113-6. PubMed ID: 10074534
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.
    Quinlan SC, Pfeiffer RM, Morton LM, Engels EA.
    Am J Hematol; 2011 Feb 27; 86(2):206-9. PubMed ID: 21264909
    [Abstract] [Full Text] [Related]

  • 19. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 20. Identifying the patient at risk for post-transplant lymphoproliferative disorder.
    Cockfield SM.
    Transpl Infect Dis; 2001 Jun 15; 3(2):70-8. PubMed ID: 11395972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.